In a filing, Health Catalyst Inc revealed its Chief People Officer Llewelyn Linda unloaded Company’s shares for reported $15648.0 on Mar 15 ’24. In the deal valued at $7.80 per share,2,005 shares were sold. As a result of this transaction, Llewelyn Linda now holds 128,231 shares worth roughly $1.0 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Burton Daniel D. bought 26,200 shares, generating $204,525 in total proceeds. Upon buying the shares at $7.81, the Chief Executive Officer now owns 1,172,623 shares.
Before that, Llewelyn Linda sold 3,262 shares. Health Catalyst Inc shares valued at $31,855 were divested by the Chief People Officer at a price of $9.77 per share. As a result of the transaction, Llewelyn Linda now holds 64,786 shares, worth roughly $0.51 million.
Evercore ISI upgraded its Health Catalyst Inc [HCAT] rating to an Outperform from a an In-line in a research note published recently. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. JP Morgan also remained covering HCAT and has increased its forecast on December 13, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Piper Sandler revised its rating on November 13, 2023. It rated HCAT as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of HCAT
On Friday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock fall -3.70% to $7.81. Over the last five days, the stock has lost -0.13%. Health Catalyst Inc shares have fallen nearly -15.66% since the year began. Nevertheless, the stocks have fallen -35.29% over the past one year. While a 52-week high of $14.37 was reached on 01/12/24, a 52-week low of $6.60 was recorded on 02/23/24. SMA at 50 days reached $9.17, while 200 days put it at $9.98. A total of 0.6 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For HCAT Stock
The 24-hour chart illustrates a support level at 7.71, which if violated will result in even more drops to 7.61. On the upside, there is a resistance level at 8.01. A further resistance level may holdings at 8.21. The Relative Strength Index (RSI) on the 14-day chart is 39.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.88%. Stochastics %K at 24.38% indicates the stock is a holding.
How much short interest is there in Health Catalyst Inc?
A steep rise in short interest was recorded in Health Catalyst Inc stocks on Feb 29, 2024, growing by 0.21 million shares to a total of 1.71 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 1.5 million shares. There was a rise of 12.28%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.34% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.78.
The most recent change occurred on August 01, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $16 price target.
